BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 28, 2026; 32(44): 120965
Published online Nov 28, 2026. doi: 10.3748/wjg.120965
Table 1 Characteristics of inflammatory bowel disease patients during periods of histologic inflammation and histologic remission in 1969-2017, n (%)/mean (interquartile range)/mean ± SD
Item
Histologic remission
Histologic inflammation
Histologic inflammation in subtypes of IBD
CD
UC
IBD-U
Number of periods4746210290426168709625774
Number of patients277795371915021356783020
Number of patients by number of periods
    117224 (62.0)30142 (56.1)8930 (59.5)19412 (54.4)1800 (59.6)
    25927 (21.3)11806 (22.0)3436 (22.9)7775 (21.8)595 (19.7)
    32443 (8.8)5561 (10.4)1418 (9.4)3891 (10.9)252 (8.3)
    ≥ 42185 (7.9)6210 (11.6)1237 (8.2)4600 (12.9)373 (12.4)
Age (years)1
mean ± SD45.9 ± 16.644.3 ± 17.641.3 ± 17.745.4 ± 17.445.5 ± 18.0
Median (IQR)46.3 (33.4-58.6)43.7 (30.5-57.6)39.9 (26.9-54.8)44.8 (31.8-58.5)45.6 (31.0-59.3)
    < 182319 (4.9)6011 (5.8)2300 (8.8)3345 (4.7)366 (6.3)
    18-4015345 (32.3)38169 (37.1)10836 (41.4)25417 (35.8)1916 (33.2)
    40-6019158 (40.4)36778 (35.7)8437 (32.2)26220 (37.0)2121 (36.7)
    ≥ 6010640 (22.4)21946 (21.3)4595 (17.6)15980 (22.5)1371 (23.7)
Calendar period1
    1969-1989 1257 (2.7)6379 (6.2)1721 (6.6)4074 (5.7)584 (10.1)
    1990-20017970 (16.8)29924 (29.1)7426 (28.4)20962 (29.5)1536 (26.6)
    2002-200915568 (32.8)32606 (31.7)8201 (31.3)23042 (32.5)1363 (23.6)
    2010-201722667 (47.8)33995 (33.0)8820 (33.7)22884 (32.3)2291 (39.7)
Educational attainment1
    0-9 years9182 (19.4)22003 (21.4)5701 (21.8)14995 (21.1)1307 (22.6)
    10-12 years20606 (43.4)43549 (42.3)11217 (42.9)30001 (42.3)2331 (40.4)
    ≥ 13 years14868 (31.3)26509 (25.8)5932 (22.7)19280 (27.2)1297 (22.5)
    Missing2806 (5.9)10843 (10.5)3318 (12.7)6686 (9.4)839 (14.5)
IBD duration (years)1
mean ± SD9.3 ± 8.66.6 ± 8.06.5 ± 8.36.5 ± 7.77.8 ± 9.5
Median (IQR)7.4 (2.1-13.8)3.5 (0.0-10.7)3.1 (0.0-10.6)3.7 (0.0-10.6)3.6 (0.0-13.2)
    01969 (4.2)28345 (27.6)7495 (28.6)19334 (27.3)1516 (26.3)
    0-516646 (35.1)29172 (28.4)7554 (28.9)20007 (28.2)1611 (27.9)
    > 528847 (60.8)45387 (44.1)11119 (42.5)31621 (44.6)2647 (45.8)
Number of health care visits2
    015871 (33.4)46294 (45.0)11082 (42.4)32667 (46.0)2545 (44.1)
    110057 (21.2)20178 (19.6)4790 (18.3)14269 (20.1)1119 (19.4)
    2-39999 (21.1)18351 (17.8)4738 (18.1)12611 (17.8)1002 (17.4)
    ≥ 411535 (24.3)18081 (17.6)5558 (21.2)11415 (16.1)1108 (19.2)
Disease history1
    Hypertension4076 (8.6)7128 (6.9)1642 (6.3)4906 (6.9)580 (10.1)
    Diabetes2232 (4.7)4272 (4.2)839 (3.2)3092 (4.4)341 (5.9)
    Obesity810 (1.7)1357 (1.3)405 (1.6)860 (1.2)92 (1.6)
    Dyslipidemia1195 (2.5)1728 (1.7)308 (1.2)1303 (1.8)117 (2.0)
    Chronic kidney diseases518 (1.1)925 (0.9)259 (1.0)590 (0.8)76 (1.3)
    COPD605 (1.3)1510 (1.5)379 (1.5)1008 (1.4)123 (2.1)
Table 2 Characteristics of inflammatory bowel disease patients during periods of clinically active and quiescent inflammatory bowel disease in 2006-2020, n (%)/mean (interquartile range)/mean ± SD
Item
Quiescent IBD
Active IBD
Active IBD in subtypes of IBD
CD
UC
IBD-U
Number of periods29328929086010862516341718818
Number of patients891148576330092490616610
Number of patients by number of periods
    130440 (34.2)28012 (32.7)9301 (30.9)16000 (32.6)2711 (41.0)
    218002 (20.2)17135 (20.0)5765 (19.2)10007 (20.4)1363 (20.6)
    312023 (13.5)11701 (13.6)4090 (13.6)6787 (13.8)824 (12.5)
    ≥ 428649 (32.2)28915 (33.7)10936 (36.3)16267 (33.2)1712 (25.9)
Age (years)1
mean ± SD49.1 ± 18.549.4 ± 18.948.4 ± 18.950.1 ± 18.649.5 ± 20.3
Median (IQR)49.2 (34.0-63.9)49.7 (34.0-64.4)48.9 (32.8-63.5)50.1 (34.9-64.8)51.3 (31.6-65.9)
    < 189177 (3.1)10442 (3.6)4716 (4.3)4565 (2.8)1161 (6.2)
    18-4093218 (31.8)89971 (30.9)34371 (31.6)50145 (30.7)5455 (29.0)
    40-6097569 (33.3)95268 (32.8)35715 (32.9)54173 (33.2)5380 (28.6)
    ≥ 6093325 (31.8)95179 (32.7)33823 (31.1)54534 (33.4)6822 (36.3)
Calendar period1
    2006-200959205 (20.2)58641 (20.2)22324 (20.6)33571 (20.5)2746 (14.6)
    2010-2020234084 (79.8)232219 (79.8)86301 (79.5)129846 (79.5)16072 (85.4)
Educational attainment1
    0-9 years57630 (19.7)58420 (20.1)22824 (21.0)31452 (19.3)4144 (22.0)
    10-12 years134083 (45.7)131664 (45.3)49786 (45.8)73827 (45.2)8051 (42.8)
    ≥ 13 years89008 (30.4)86096 (29.6)29736 (27.4)51397 (31.5)4963 (26.4)
    Missing12568 (4.3)14680 (5.1)6279 (5.8)6741 (4.1)1660 (8.8)
IBD duration (years)1
mean ± SD10.8 ± 10.311.1 ± 10.411.9 ± 11.210.7 ± 9.69.9 ± 12.0
Median (IQR)8.1 (2.4-16.1)8.4 (2.7-16.5)8.9 (2.8-18.1)8.5 (3.0-15.7)4.8 (0.6-15.1)
    026271 (9.0)31739 (10.9)12445 (11.5)15632 (9.6)3662 (19.5)
    0-581444 (27.8)70892 (24.4)24951 (23.0)40040 (24.5)5901 (31.4)
    > 5185574 (63.3)188229 (64.7)71229 (65.6)107745 (65.9)9255 (49.2)
Number of health care visits2
    061932 (21.1)63613 (21.9)22132 (20.4)37306 (22.8)4175 (22.2)
    155308 (18.9)55407 (19.1)20357 (18.7)32021 (19.6)3029 (16.1)
    2-371211 (24.3)70586 (24.3)25853 (23.8)40455 (24.8)4278 (22.7)
    ≥ 4104838 (35.8)101254 (34.8)40283 (37.1)53635 (32.8)7336 (39.0)
Disease history1
    Hypertension48248 (16.5)46986 (16.2)16920 (15.6)26097 (16.0)3969 (21.1)
    Diabetes20635 (7.0)20188 (6.9)6228 (5.7)12357 (7.6)1603 (8.5)
    Obesity10753 (3.7)10531 (3.6)3982 (3.7)5671 (3.5)878 (4.7)
    Dyslipidemia12545 (4.3)12076 (4.2)3426 (3.2)7671 (4.7)979 (5.2)
    Chronic kidney diseases7353 (2.5)7400 (2.5)2937 (2.7)3831 (2.3)632 (3.4)
    COPD12405 (4.2)12488 (4.3)5020 (4.6)6369 (3.9)1099 (5.8)


Write to the Help Desk